These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1387314)

  • 1. Metabolism of NAD(P)H by blood components. Relevance to bioreductively activated prodrugs in a targeted enzyme therapy system.
    Friedlos F; Knox RJ
    Biochem Pharmacol; 1992 Aug; 44(4):631-5. PubMed ID: 1387314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virtual cofactors for an Escherichia coli nitroreductase enzyme: relevance to reductively activated prodrugs in antibody directed enzyme prodrug therapy (ADEPT).
    Knox RJ; Friedlos F; Jarman M; Davies LC; Goddard P; Anlezark GM; Melton RG; Sherwood RF
    Biochem Pharmacol; 1995 May; 49(11):1641-7. PubMed ID: 7786305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of CB 1954 cytotoxicity by reduced pyridine nucleotides in human tumour cells by stimulation of DT diaphorase activity.
    Friedlos F; Biggs PJ; Abrahamson JA; Knox RJ
    Biochem Pharmacol; 1992 Nov; 44(9):1739-43. PubMed ID: 1449531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Auxiliary NADH Dehydrogenase Plays a Crucial Role in Redox Homeostasis of Nicotinamide Cofactors in the Absence of the Periplasmic Oxidation System in Gluconobacter oxydans NBRC3293.
    Sriherfyna FH; Matsutani M; Hirano K; Koike H; Kataoka N; Yamashita T; Nakamaru-Ogiso E; Matsushita K; Yakushi T
    Appl Environ Microbiol; 2021 Jan; 87(2):. PubMed ID: 33127815
    [No Abstract]   [Full Text] [Related]  

  • 5. Bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by human NAD(P)H quinone oxidoreductase 2: a novel co-substrate-mediated antitumor prodrug therapy.
    Knox RJ; Jenkins TC; Hobbs SM; Chen S; Melton RG; Burke PJ
    Cancer Res; 2000 Aug; 60(15):4179-86. PubMed ID: 10945627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase.
    Wu K; Knox R; Sun XZ; Joseph P; Jaiswal AK; Zhang D; Deng PS; Chen S
    Arch Biochem Biophys; 1997 Nov; 347(2):221-8. PubMed ID: 9367528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel reduced pyridinium derivatives as synthetic co-factors for the enzyme DT diaphorase (NAD(P)H dehydrogenase (quinone), EC 1.6.99.2).
    Friedlos F; Jarman M; Davies LC; Boland MP; Knox RJ
    Biochem Pharmacol; 1992 Jul; 44(1):25-31. PubMed ID: 1385952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
    Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioactivation of dinitrobenzamide mustards by an E. coli B nitroreductase.
    Anlezark GM; Melton RG; Sherwood RF; Wilson WR; Denny WA; Palmer BD; Knox RJ; Friedlos F; Williams A
    Biochem Pharmacol; 1995 Aug; 50(5):609-18. PubMed ID: 7669063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The bioactivation of CB 1954 and its use as a prodrug in antibody-directed enzyme prodrug therapy (ADEPT).
    Knox RJ; Friedlos F; Boland MP
    Cancer Metastasis Rev; 1993 Jun; 12(2):195-212. PubMed ID: 8375021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The vanadate-stimulated oxidation of NAD(P)H by biomembranes is a superoxide-initiated free radical chain reaction.
    Liochev S; Fridovich I
    Arch Biochem Biophys; 1986 Oct; 250(1):139-45. PubMed ID: 3021060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of histidine-194, aspartate-163, and a glycine-rich sequence of NAD(P)H:quinone oxidoreductase in the interaction with nicotinamide coenzymes.
    Cui K; Ma Q; Lu AY; Yang CS
    Arch Biochem Biophys; 1995 Nov; 323(2):265-73. PubMed ID: 7487087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonenzymic hydrogen transfer between reduced and oxidized pyridine nucleotides.
    Bernofsky C; Gallagher WJ
    Biochim Biophys Acta; 1981 May; 659(1):1-6. PubMed ID: 7248310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of the activation of prodrug CB 1954 using human DT-diaphorase mutant Q104Y-transfected MDA-MB-231 cells and mouse xenograft model.
    Wu K; Eng E; Knox R; Chen S
    Arch Biochem Biophys; 2001 Jan; 385(1):203-8. PubMed ID: 11361019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unexpected genetic and structural relationships of a long-forgotten flavoenzyme to NAD(P)H:quinone reductase (DT-diaphorase).
    Zhao Q; Yang XL; Holtzclaw WD; Talalay P
    Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1669-74. PubMed ID: 9050836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydronicotinamide riboside is a potent NAD
    Yang Y; Mohammed FS; Zhang N; Sauve AA
    J Biol Chem; 2019 Jun; 294(23):9295-9307. PubMed ID: 30948509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of diaziquone by NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase): role in diaziquone-induced DNA damage and cytotoxicity in human colon carcinoma cells.
    Siegel D; Gibson NW; Preusch PC; Ross D
    Cancer Res; 1990 Nov; 50(22):7293-300. PubMed ID: 2121335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extraction and Quantitation of Nicotinamide Adenine Dinucleotide Redox Cofactors.
    Lu W; Wang L; Chen L; Hui S; Rabinowitz JD
    Antioxid Redox Signal; 2018 Jan; 28(3):167-179. PubMed ID: 28497978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential utilization of NADPH as the endogenous electron donor for NAD(P)H:quinone oxidoreductase 1 (NQO1) in intact pulmonary arterial endothelial cells.
    Bongard RD; Lindemer BJ; Krenz GS; Merker MP
    Free Radic Biol Med; 2009 Jan; 46(1):25-32. PubMed ID: 18848878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of DT-diaphorase (NAD(P)H:quinone oxidoreductase, EC 1.6.99.2) by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and flavone-8-acetic acid (FAA): implications for bioreductive drug development.
    Phillips RM
    Biochem Pharmacol; 1999 Jul; 58(2):303-10. PubMed ID: 10423172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.